Gsk (GSK) Common Equity (2009 - 2026)
Gsk (GSK) recorded Common Equity of $24.3 billion in the quarter ended Sep 30, 2026, up 14.8% from $21.17 billion a year earlier and up 6.7% from the prior quarter.
Gsk (GSK) Common Equity (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Gsk reported Common Equity of $22.06 billion, up 28.6% from the prior year.
- Annual Common Equity has increased for three straight years, though with a five-year compound annual growth rate of -4.9% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Common Equity came in at $17.16 billion in the year ended Dec 31, 2024 (+0.9%), $17 billion in the year ended Dec 31, 2023 (+33.0%), $12.78 billion in the year ended Dec 31, 2022 (-55.6%) and $28.81 billion in the year ended Dec 31, 2021 (+1.6%).
- The figure for the quarter ended Sep 30, 2026 is the highest quarterly Common Equity since the quarter ended Jun 30, 2022.
- On a year-over-year basis, Common Equity has increased for 13 consecutive quarters, with growth averaging 15.8% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 58.2% in the quarter ended Sep 30, 2023, against a decline of 66.7% in the quarter ended Sep 30, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $22.77 billion (quarter ended Jun 30, 2026), $22.95 billion (quarter ended Mar 31, 2026) and $22.06 billion (quarter ended Dec 31, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | 12.96 Bn |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn | 24.30 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.30 Bn |
| Jun 30, 2026 | 22.77 Bn |
| Mar 31, 2026 | 22.95 Bn |
| Dec 31, 2025 | 22.06 Bn |
| Sep 30, 2025 | 21.17 Bn |
| Jun 30, 2025 | 19.69 Bn |
| Mar 31, 2025 | 17.67 Bn |
| Dec 31, 2024 | 17.16 Bn |
| Sep 30, 2024 | 18.00 Bn |
| Jun 30, 2024 | 17.41 Bn |
| Mar 31, 2024 | 16.70 Bn |
| Dec 31, 2023 | 17.00 Bn |
| Sep 30, 2023 | 15.40 Bn |
| Jun 30, 2023 | 15.34 Bn |
| Mar 31, 2023 | 14.01 Bn |
| Dec 31, 2022 | 12.78 Bn |
| Sep 30, 2022 | 9.74 Bn |
| Jun 30, 2022 | 27.47 Bn |
| Mar 31, 2022 | 35.28 Bn |
| Dec 31, 2021 | 28.81 Bn |
Gsk Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();